The clinical manifestation of coronavirus disease 2019 (COVID‐19) mainly targets the lung
as a primary affected organ, which is also a critical site of immune cell activation by severe …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), could affect brain structure and function. SARS-CoV …

Infection with the etiological agent of COVID-19, SARS-CoV-2, appears capable of
impacting cognition in some patients with post-acute sequelae of SARS-CoV-2 (PASC). To …

In late December 2019, severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-
2) was discovered following a cluster of pneumonia cases in Wuhan, China. During the early …

Abstract SARS‐CoV‐2, the etiological agent of COVID-19, is devoid of any metabolic
capacity; therefore, it is critical for the viral pathogen to hijack host cellular metabolic …

Introduction Cognitive impairment is experienced by people with myalgic encephalomyelitis/
chronic fatigue syndrome (ME/CFS) and post-acute sequelae of COVID-19 (PASC). Patients …

Background COVID-19, a serious respiratory disease that has the potential to affect
numerous organs, is a serious threat to the health of people around the world. The objective …

The 2019 novel coronavirus disease (COVID-19) has lasted for over 3 years and has
seriously affected the regular life trajectory of human beings. The severe acute respiratory …

Introduction Neurological/neuropsychiatric symptoms are commonly reported by
children/young people with long COVID, especially headache, fatigue, cognitive deficits …

Cognitive sequelae after recovery from an initial COVID-19 disease are present in a subset
of affected individuals, coalescing around several important issues such as effects of age …